- Home
- TNON vs CODX Comparison
TNON vs CODX Comparison
Compare TNON & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- CODX
- Stock Information
- Founded
- TNON 2012
- CODX 2013
- Country
- TNON United States
- CODX United States
- Employees
- TNON N/A
- CODX N/A
- Industry
- TNON Medical Specialities
- CODX Medical/Dental Instruments
- Sector
- TNON Health Care
- CODX Health Care
- Exchange
- TNON Nasdaq
- CODX Nasdaq
- Market Cap
- TNON 11.5M
- CODX 9.8M
- IPO Year
- TNON 2022
- CODX 2017
- Fundamental
- Price
- TNON $1.17
- CODX $0.42
- Analyst Decision
- TNON Strong Buy
- CODX Buy
- Analyst Count
- TNON 2
- CODX 2
- Target Price
- TNON $5.50
- CODX $5.50
- AVG Volume (30 Days)
- TNON 269.5K
- CODX 13.6M
- Earning Date
- TNON 11-12-2025
- CODX 11-06-2025
- Dividend Yield
- TNON N/A
- CODX N/A
- EPS Growth
- TNON N/A
- CODX N/A
- EPS
- TNON N/A
- CODX N/A
- Revenue
- TNON $2,947,000.00
- CODX $1,003,653.00
- Revenue This Year
- TNON $43.52
- CODX N/A
- Revenue Next Year
- TNON $82.14
- CODX $31.58
- P/E Ratio
- TNON N/A
- CODX N/A
- Revenue Growth
- TNON N/A
- CODX N/A
- 52 Week Low
- TNON $0.85
- CODX $0.23
- 52 Week High
- TNON $7.51
- CODX $1.40
- Technical
- Relative Strength Index (RSI)
- TNON 44.55
- CODX 56.81
- Support Level
- TNON $1.13
- CODX $0.30
- Resistance Level
- TNON $1.26
- CODX $0.72
- Average True Range (ATR)
- TNON 0.07
- CODX 0.06
- MACD
- TNON -0.01
- CODX 0.02
- Stochastic Oscillator
- TNON 26.09
- CODX 28.32
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.